Results 11 to 20 of about 123,872 (261)
Beta-blockers for hypertension [PDF]
Cochrane Database of Systematic Reviews, 2017 Beta-blockers refer to a mixed group of drugs with diverse pharmacodynamic and pharmacokinetic properties. They have shown long-term beneficial effects on mortality and cardiovascular disease (CVD) when used in people with heart failure or acute myocardial infarction. Beta-blockers were thought to have similar beneficial effects when used as first-line
Wiysonge, Charles S. +4 more
openaire +3 more sources
BETA-BLOCKERS IN THE TREATMENT OF ARTERIAL HYPERTENSION: EVIDENCE BASED DATA AND REAL PRACTICE
Рациональная фармакотерапия в кардиологии, 2015 Data of the largest meta-analyzes of beta-blockers use in arterial hypertension is presented. The role of beta-blockers among other basic groups of antihypertensive drugs (thiazide diuretics, calcium channel blockers, ACE inhibitors) is evaluated ...
M. V. Leonova
doaj +3 more sources
BMC Cardiovascular Disorders, 2021 Background The aim of this study was to determine the difference in effects of beta-blockers on long-term clinical outcomes between ischemic heart disease (IHD) patients with mid-range ejection fraction (mrEF) and those with reduced ejection fraction ...
Jun Shitara +12 more
doaj +1 more source
Respiratory Research, 2017 Background Beta-blockers are commonly prescribed for patients with cardiovascular disease. Providers have been wary of treating chronic obstructive pulmonary disease (COPD) patients with beta-blockers due to concern for bronchospasm, but retrospective ...
Sean Duffy +26 more
doaj +1 more source
Drug Use Evaluation of Beta-Blockers in Medical Wards of Nedjo General Hospital, Western Ethiopia
Cardiovascular Therapeutics, 2020 Introduction. Beta-blocker use evaluation is a performance method that focuses on the evaluation of beta-blocker use processes to achieve optimal patient outcomes.
Ginenus Fekadu +5 more
doaj +1 more source
Ukrainian Scientific Medical Youth Journal, 2022 the article presents the results of the study of impact of the reimbursement program “Affordable medicines” on consumption of beta-blockers in Ukraine, used for treatment of cardiovascular diseases.
Anton Gonchar, Natalia Sholoiko
doaj +1 more source
Journal of Hepatology, 2014 might have stumbled across other rather informative (and much We read with interest the recent review on beta-blockers in cirrhosis by Ge and Runyon [1]. This topic is of great importance, as non-selective beta blockers are a pharmacological mainstay in the management of patients with cirrhosis; the amount of evidence has been increasing substantially ...
Thalheimer, Ulrich +2 more
openaire +2 more sources
The Impact of beta blockade on the cardio-respiratory system and symptoms during exercise
Current Research in Physiology, 2021 Background: Beta blockers prolong life in patients with cardiovascular diseases. Negative chronotropic and inotropic effects carry the potential to adversely effect peripheral skeletal and airway smooth muscle contributing to further fatigue, dyspnea and
Eldar Priel +6 more
doaj +1 more source
A Clinical-Epidemiological Study on Beta-Blocker Poisonings Based on the Type of Drug Overdose
Journal of Toxicology, 2023 Background. Beta‐blockers carry a high risk of potentially causing fatal poisoning if overdosed. We aimed to assess the clinical and epidemiological characteristics of patients with beta-blocker poisoning. Methods.
Nastaran Eizadi-Mood +4 more
doaj +1 more source
Beta-blockers in Cardiovascular Therapy: A Review
Journal of Mind and Medical Sciences, 2019 The role of beta-adrenergic receptor antagonists in cardiovascular therapy has been the subject of various studies over time, these agents representing one of the oldest class of drugs used for the treatment of cardiovascular diseases.
Camelia C. Diaconu +7 more
doaj +1 more source